H.R. 1294 (105th): To amend title 10, United States Code, to require the Secretary of Defense to provide to members of the Armed Forces who receive an investigational new drug relevant information regarding the drug, including the possible side effects of the drug.

Introduced:
Apr 10, 1997 (105th Congress, 1997–1998)
Status:
Died (Referred to Committee)
Sponsor
Patrick Kennedy
Representative for Rhode Island's 1st congressional district
Party
Democrat
Text
Read Text »
Last Updated
Apr 10, 1997
Length
3 pages
Related Bills
H.R. 1119 (Related)
National Defense Authorization Act for Fiscal Year 1998

Signed by the President
Nov 18, 1997

 
Status

This bill was introduced on April 10, 1997, in a previous session of Congress, but was not enacted.

Progress
Introduced Apr 10, 1997
Referred to Committee Apr 10, 1997
 
Summary

No summaries available.

Cosponsors
none
Committees

House Armed Services

Military Personnel

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


4/10/1997--Introduced.
Amends provisions governing the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS) to provide that, whenever the Secretary of Defense requests or requires a member of the armed forces to receive an investigational new drug, the Secretary shall provide such member a notice identifying such drug as an investigational new drug, giving the reasons why such drug is being administered and disclosing possible side effects.
Requires such notice to be provided before such drug is administered, if practicable, but in no case no later than 30 days afterwards.
Requires the Secretary to report to the Congress the reasons a form of notice other than written notice is used.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 1294 (105th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus